How to maintain the maximal level of blinding in randomisation for a placebo-controlled drug trial. (2019)
Attributed to:
ASPIRE: Automated Sensing & Predictive Inference for Respiratory Exacerbation
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.conctc.2019.100356
PubMed Identifier: 31011659
Publication URI: http://europepmc.org/abstract/MED/31011659
Type: Journal Article/Review
Volume: 14
Parent Publication: Contemporary clinical trials communications
ISSN: 2451-8654